Detalles de la búsqueda
1.
Phase I/IIa study of intratumoral/intracerebral or intravenous/intracerebral administration of Parvovirus H-1 (ParvOryx) in patients with progressive primary or recurrent glioblastoma multiforme: ParvOryx01 protocol.
BMC Cancer
; 12: 99, 2012 Mar 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-22436661
2.
Improved killing of human high-grade glioma cells by combining ionizing radiation with oncolytic parvovirus H-1 infection.
J Biomed Biotechnol
; 2010: 350748, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20224643
3.
Therapeutic implications of the enhanced short and long-term cytotoxicity of radiation treatment followed by oncolytic parvovirus H-1 infection in high-grade glioma cells.
Bioeng Bugs
; 1(6): 429-33, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-21468212
4.
Oncolytic parvoviruses as cancer therapeutics.
Cytokine Growth Factor Rev
; 21(2-3): 185-95, 2010.
Artículo
en Inglés
| MEDLINE | ID: mdl-20211577
5.
Adeno-associated virus infection and cervical neoplasia: is there a protective role against human papillomavirus-related carcinogenesis?
Eur J Cancer Prev
; 17(4): 364-8, 2008 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-18562963
6.
Parvovirus H-1 infection of human glioma cells leads to complete viral replication and efficient cell killing.
Int J Cancer
; 109(1): 76-84, 2004 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-14735471
7.
Prevention of chemotherapy-related toxic side effects by infection with adeno-associated virus type 2.
Int J Cancer
; 100(5): 606-14, 2002 Aug 10.
Artículo
en Inglés
| MEDLINE | ID: mdl-12124812
Resultados
1 -
7
de 7
1
Próxima >
>>